Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imaging

We show here that hyperpolarized [1‐13C]pyruvate can be used to detect treatment response in a glioma tumor model; a tumor type where detection of response with 18fluoro‐2‐deoxyglucose, using positron emission tomography, is limited by the high background signals from normal brain tissue. 13C chemical shift images acquired following intravenous injection of hyperpolarized [1‐13C]pyruvate into rats with implanted C6 gliomas showed significant labeling of lactate within the tumors but comparatively low levels in surrounding brain.Labeled pyruvate was observed at high levels in blood vessels above the brain and from other major vessels elsewhere but was detected at only low levels in tumor and brain.The ratio of hyperpolarized 13C label in tumor lactate compared to the maximum pyruvate signal in the blood vessels was decreased from 0.38 ± 0.16 to 0.23 ± 0.13, (a reduction of 34%) by 72 h following whole brain irradiation with 15 Gy. Magn Reson Med, 2011. © 2010 Wiley‐Liss, Inc.

[1]  Yue Cao,et al.  Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT , 2006 .

[2]  I. Whittle,et al.  Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours , 1998, Journal of Neuro-Oncology.

[3]  Y. Muragaki,et al.  Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography , 2008, American Journal of Neuroradiology.

[4]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[5]  Lutz Tellmann,et al.  Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. , 2009, Nuclear medicine and biology.

[6]  Yasushi Ishii,et al.  Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. , 1997, Investigative radiology.

[7]  T. Mcknight,et al.  Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. , 2004, Seminars in oncology.

[8]  Adolf Pfefferbaum,et al.  Metabolic imaging in the anesthetized rat brain using hyperpolarized [1‐13C] pyruvate and [1‐13C] ethyl pyruvate , 2010, Magnetic resonance in medicine.

[9]  J. Voges,et al.  In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.

[10]  Yue Cao,et al.  Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. , 2006, International journal of radiation oncology, biology, physics.

[11]  Dieta Brandsma,et al.  Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide , 2008, Cancer.

[12]  M. Martínez-Bisbal,et al.  Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[13]  S. Williams,et al.  In vivo NMR spectroscopy: Principles and techniques, R.A. de Graaf, Wiley, Chichester, 1998, Hardback £120 ISBN 0-471-98365-9 , 1999 .

[14]  S J Kohler,et al.  Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C‐pyruvate , 2009, Magnetic resonance in medicine.

[15]  J. Walecki,et al.  1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. , 2002, International journal of radiation oncology, biology, physics.

[16]  Ferdia A Gallagher,et al.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.

[17]  R. Auer,et al.  Le Journal Canadien Des Sciences Neurologiques a Simple and Reproducible Experimental in Vivo Glioma Model , 2022 .

[18]  F A Howe,et al.  The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. , 2007, Clinical radiology.

[19]  Adolf Pfefferbaum,et al.  Application of subsecond spiral chemical shift imaging to real‐time multislice metabolic imaging of the rat in vivo after injection of hyperpolarized 13C1‐pyruvate , 2009, Magnetic resonance in medicine.

[20]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[21]  Joël Mispelter,et al.  NMR Probeheads for Biophysical and Biomedical Experiments: Theoretical Principles and Practical Guidelines , 2006 .

[22]  Rebekah McLaughlin,et al.  Magnetization transfer measurements of exchange between hyperpolarized [1‐13C]pyruvate and [1‐13C]lactate in a murine lymphoma , 2010, Magnetic resonance in medicine.

[23]  R Gruetter,et al.  Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. , 1998, Cancer research.

[24]  Ilwoo Park,et al.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. , 2010, Neuro-oncology.